Hiroyuki Hagiwara

Dr. Hiroyuki Hagiwara


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
HTHideyuki Takahashi
Hideyuki Takahashi
HHHiroyuki Hagiwara
Hiroyuki Hagiwara
HTHiroe Tada
Hiroe Tada
MUMiho Uchida
Miho Uchida
TMToshiyuki Matsuyama
Toshiyuki Matsuyama
KCKazuaki Chikamatsu
Kazuaki Chikamatsu
Background /Objectives: Head and neck squamous cell carcinoma (HNSCC) is a biologically heterogeneous malignancy with poor outcomes in advanced disease. Increasing evidence indicates that the tumor microenvironment, particularly cancer-associated fibroblasts (CAFs), plays an important role in tumor progression and immune regulation. However, the diversity of CAF subsets and their clinical relevance in HNSCC remain incompletely understood. This study aimed to characterize CAF heterogeneity and assess the prognostic significance of CAF subset-specific transcriptional programs. Methods: Single-cell RNA sequencing data from HNSCC tumors were analyzed to identify CAF subsets based on differentially expressed genes. CAF subset-specific gene signatures were used to construct prognostic risk models for overall survival (OS) and progression-free survival (PFS) in The Cancer Genome Atlas HNSCC cohort, with validation in an independent dataset. CAF-driven prognostic groups were defined, and their immune landscapes and biological pathways were evaluated. Bulk RNA sequencing of primary CAF cultures was performed for validation. Results: Six CAF subsets were identified, including myofibroblastic (myCAF), inflammatory (iCAF), antigen-presenting, and extracellular matrix-related CAFs. Risk scores derived from inflammatory CAF subsets consistently predicted shorter OS across independent cohorts, whereas PFS prediction showed greater cohort dependency. CAF-based stratification identified patient subgroups with distinct immune profiles and pathway enrichment patterns. These results were supported by validation analyses and by bulk RNA sequencing of primary CAFs, demonstrating preservation of myCAF- and iCAF-like transcriptional programs ex vivo. Conclusions: CAF heterogeneity has important prognostic and immunological implications in HNSCC. Inflammatory CAF-related transcriptional programs represent robust markers of patient survival and may complement tumor-intrinsic biomarkers.

18 May 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
HTHideyuki Takahashi
Hideyuki Takahashi
HHHiroyuki Hagiwara
Hiroyuki Hagiwara
HTHiroe Tada
Hiroe Tada
MUMiho Uchida
Miho Uchida
TMToshiyuki Matsuyama
Toshiyuki Matsuyama
KCKazuaki Chikamatsu
Kazuaki Chikamatsu
Zinc transport plays a critical role in cellular signaling, but its function in the tumor microenvironment remains poorly understood. We aimed to investigate the role of zinc transporters in cancer-associated fibroblasts in head and neck squamous cell carcinoma. Single-cell RNA sequencing data were analyzed to evaluate zinc transporter expression across tumor cell populations, and bulk RNA sequencing of primary fibroblast cultures was used for validation. Clinical relevance was assessed using transcriptomic and survival data from a large patient cohort. We found that zinc transporter expression, particularly SLC39A13, was enriched in fibroblasts and strongly associated with myofibroblastic activation signatures, including extracellular matrix remodeling and TGFβ signaling. Fibroblasts with high SLC39A13 expression were linked to immunosuppressive tumor environments characterized by reduced cytotoxic T-cell infiltration and increased immunosuppressive cells. Clinically, SLC39A13 expression was associated with poor progression-free survival and remained an independent prognostic factor. These findings suggest that zinc transporter-mediated pathways play a key role in stromal activation and immune regulation, highlighting SLC39A13 as a potential therapeutic target in head and neck squamous cell carcinoma.

19 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
HTHideyuki Takahashi
Hideyuki Takahashi
TMToshiyuki Matsuyama
Toshiyuki Matsuyama
HTHiroe Tada
Hiroe Tada
HHHiroyuki Hagiwara
Hiroyuki Hagiwara
MUMiho Uchida
Miho Uchida
KCKazuaki Chikamatsu
Kazuaki Chikamatsu
Objectives: Innate lymphoid cells (ILCs) and natural killer (NK) cells represent a diverse group of innate immune populations that modulate immune responses and tissue equilibrium across various diseases, including cancer. In the present study, we analyzed single-cell RNA sequencing (scRNA-seq) data to explore the landscape and functional status of ILC subsets in patients with head and neck squamous cell carcinoma (HNSCC). Methods: The GSE164690 dataset, which includes preprocessed scRNA-seq and clinical data, was acquired from the Gene Expression Omnibus database. The Cancer Genome Atlas database was used to develop the survival prediction model. Results: A total of 95,809 immune cells were clustered into 16 immune cell clusters, among which 7278 NK cells were further subdivided into 11 clusters. Among the 11 clusters, eight NK cell clusters, two intraepithelial ILC1 (ieILC1) clusters, and one ieILC1–NK-intermediate (ieILC1-NK-int) cluster were identified. Among the ieILC1/NK clusters, ieILC1-1 exhibited the highest immunological activity and was mainly derived from human papillomavirus-positive samples. Further, ieILC1s showed higher enrichment of pathways related to inflammation and effector functions—such as inflammatory response, interferon-gamma response, and interferon-alpha response—compared to the other clusters. Moreover, we developed prognostic prediction models based on differentially expressed genes in the ieILC1/NK clusters. Risk scores of the ieILC1-1, ieILC1-NK-int, and NK clusters were identified as independent prognostic factors for shorter overall survival (OS) and progression-free survival (PFS). Recursive partitioning revealed that combining ieILC1-1 and the NK clusters strongly predicted shorter OS and PFS. Conclusions: Our findings highlight the diverse landscape and prognostic significance of ieILC1/NK cells in patients with HNSCC.

24 September 2026 in Cancers
Verified
Journal Article
Open access
PDF file
HTHideyuki Takahashi
Hideyuki Takahashi
MUMiho Uchida
Miho Uchida
KTKaoru Takahashi
Kaoru Takahashi
HHHiroyuki Hagiwara
Hiroyuki Hagiwara
HTHiroe Tada
Hiroe Tada
KCKazuaki Chikamatsu
Kazuaki Chikamatsu
Background/Objectives: Zinc homeostasis has emerged as an important regulator of cancer biology, yet the biological and clinical significance of zinc transporter-associated transcriptional programs in head and neck squamous cell carcinoma (HNSCC) remains poorly understood. This study aimed to identify zinc transporter-associated epithelial tumor cell states and evaluate their molecular and clinical significance. Methods: Single-cell RNA sequencing data from an HNSCC cohort were analyzed to identify epithelial tumor cell populations associated with zinc transporter expression and to characterize their molecular features. A ZIP-active transcriptional signature was subsequently applied to The Cancer Genome Atlas (TCGA)-HNSCC cohort to evaluate biological characteristics, immune features, survival outcomes, and the influence of NFE2L2/KEAP1/CUL3 mutation status. Results: A distinct epithelial tumor cell population characterized by coordinated upregulation of SLC39A3 and SLC39A4 was identified and designated the ZIP-active tumor cell state. This population showed NRF2-associated oxidative stress adaptation, glutathione metabolism, and ferroptosis suppression, together with increased NRF2 activity. In the TCGA-HNSCC cohort, a high ZIP-active score was associated with oxidative stress adaptation, reduced T-cell-related immune signatures, and poorer overall survival. NFE2L2/KEAP1/CUL3-mutant tumors showed higher ZIP-active and NRF2-related scores than wild-type tumors, while NRF2-related metabolic features remained associated with ZIP activity in both groups. Conclusions: The ZIP-active tumor cell state represents an NRF2-linked metabolic program associated with oxidative stress adaptation, immune alterations, and adverse prognosis in HNSCC. Its persistence across NFE2L2/KEAP1/CUL3 mutation groups suggests that ZIP activity reflects NRF2-related tumor biology beyond genomic alterations alone.